Lori D Lawley Lumos Pharma, Inc. (LUMO) insider trading activity

Lori D Lawley is Chief Financial Officer of LUMOS PHARMA, INC.. Currently has a direct ownership of 0 shares of LUMO, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2024, when has been sold 12,284 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Lori D Lawley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2024	SELL Sale (or disposition) back to the issuer	-	12,284 Reduced 100.0%	0 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$409 $1.79 p/Share	229 Reduced 1.83%	12,284 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$778 $2.84 p/Share	274 Reduced 2.14%	12,513 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$2,840 $2.84 p/Share	1,000 Added 7.25%	12,787 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$647 $3.01 p/Share	215 Reduced 1.79%	11,787 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$751 $3.28 p/Share	229 Reduced 1.95%	11,502 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$906 $3.31 p/Share	274 Reduced 2.38%	11,231 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$401 $3.52 p/Share	114 Reduced 0.98%	11,505 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	$3,520 $3.52 p/Share	1,000 Added 7.92%	11,619 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$1,871 $8.17 p/Share	229 Reduced 2.21%	10,119 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$2,529 $9.23 p/Share	274 Reduced 2.71%	9,848 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$651 $10.02 p/Share	65 Reduced 0.64%	10,122 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	$10,020 $10.02 p/Share	1,000 Added 8.94%	10,187 Common Stock
Aug 01 2021	BUY Grant, award, or other acquisition	-	3,750 Added 28.99%	9,187 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$3,356 $12.25 p/Share	274 Reduced 4.8%	5,437 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	869 Added 13.21%	5,711 Common Stock

LDL

Lori D Lawley

Chief Financial Officer

Austin, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Value

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO

Account